Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge | Zendy

Jesús RodríguezBaño | Zendy; M.D. Navarro | Zendy; Luis M. Beltrán | Zendy; Miguel A. Muniain | Zendy; Marina de Cueto | Zendy; Mateo Ríos | Zendy; Joaquí­n Hernández Bermúdez | Zendy; Álvaro Pascual | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge

Author(s) -

Jesús RodríguezBaño,

M.D. Navarro,

Luis M. Beltrán,

Miguel A. Muniain,

Marina de Cueto,

Mateo Ríos,

Joaquín Hernández Bermúdez,

Álvaro Pascual

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/508877

Subject(s) - medicine , bacteremia , cephalosporin , carbapenem , sepsis , antimicrobial , context (archaeology) , microbiology and biotechnology , escherichia coli , urinary system , cefepime , gastroenterology , antibiotics , antibiotic resistance , biology , imipenem , gene , paleontology , biochemistry

Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, particularly those producing CTX-M types of ESBL, are emerging pathogens. Bacteremia caused by these organisms represents a clinical challenge, because the organisms are frequently resistant to the antimicrobials recommended for treatment of patients with suspected E. coli sepsis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research